Sign inJoin waitlistJoin the waitlist

AS

Anita Scribner

Physician · Special Health Resources for Texas

Credentials: · · · · ·

History

Special Health Resources for Texas
2020–Present

Infectious Disease
UT Southwestern Medical School *
1997–1999
Indiana University School of Medicine
1994–1997
McGovern Medical School at The University of Texas Health Science Center at Houston
1990–1994

Research

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study
Journal of acquired immune deficiency syndromes · 2015 · 134 citations
Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled,…
The Lancet HIV · 2023 · 98 citations
Osteonecrosis in HIV: a case-control study
Journal of acquired immune deficiency syndromes · 2000 · First of 11 authors · 97 citations

Cheryl McDonald
3 papers
GC
Gordon Crofoot
3 papers
MR
Moti Ramgopal
3 papers
MR
Martin Rhee
2 papers
Mezgebe Berhe
2 papers
PR
Peter Ruane
2 papers
Samir Gupta
2 papers
WS
William Sanchez
2 papers
AM
Anthony Mills
1 paper
CC
Calvin Cohen
1 paper
DS
Daniel Skiest
1 paper
David Marcantonio
1 paper

Clinical trials

Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests
Principal investigator · Completed
LumiraDx UK Limited
2020–2022
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Site PI · Recruiting · Phase 2
ViiV Healthcare
2026–2028